Trinity Capital Inc. Provides $20 Million in Growth Capital to ABM Respiratory Care to Advance Breathing Therapies
PR Newswire•20/10/2026•08:00 ET
0
Key Highlights
- ➤Trinity Capital commits $20 million in growth capital to ABM Respiratory Care
- ➤ABMRC will accelerate commercial expansion and global market presence
- ➤ABMRC will fund product innovation, clinical research, and connected respiratory technologies
Expert Statements
Rob Lake, Senior Managing Director, Healthcare & Life Sciences at Trinity Capital
“For patients with compromised respiratory systems, clearing the lungs and breathing comfortably takes real effort and the right technology. We believe ABM Respiratory Care builds that technology, and we are proud to support the team as they work to bring it to more patients around the world.”
Greg Miller, Chief Executive Officer of ABM Respiratory Care
“This financing represents another significant milestone in ABM Respiratory Care's growth and financial evolution. Building on our current strong commercial momentum, our partnership with Trinity Capital strengthens our financial foundation and provides the capital and operating flexibility to accelerate strategic growth initiatives, expand our presence in existing and new markets, and bring our innovative respiratory care technologies to more patients and healthcare providers worldwide.”
Trinity Capital Inc. Provides $20 Million in Growth Capital to ABM Respiratory Care to Advance Breathing Therapies PR Newswire
PHOENIX, Oct. 20, 2026 /PRNewswire/ -- Trinity Capital Inc. (NYSE: TRIN) (the "Company"), a leading international alternative asset manager, today announced the commitment of $20 million in growth capital to ABM Respiratory Care (ABMRC), a medical technology company focused on developing and globally commercializing novel airway clearance and ventilation solutions.
Get started
Create a free account to read the full story.